3Hochsmann B, Rojewski M, Schrezenmeier H, et al. Paroxysmal noc- turnal hemoglobinuria (PNH) :higher sensitivity and validity in diag- nosis and serial monitoring by flow cytometric analysis of reticulo- cytes [ J ]. Ann Hematol, 2011,90 : 887 - 899.
4Diep DB, Nelson KL, Raja SM, et al. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin [ J ]. J Biol Chem, 1998, 273 :2355 -2360.
5Mortazavi Y, Merk B, Mclntosh J,et al. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturualhemoglobinuria (AA/PNH) :a high incidence of multiple mutations and evidence of a mutational hot spot[ J]. Blood ,2003,101:2833 - 2841.
6Roth A, Hock C, Konik A, et al. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab:safety,efficacy, and unexpected laboratory phenomena[ J]. Int J Hematol,2011,93 : 704 -714.
7Brodsky RA, Luznik L, Bolanos-Meade J. Reduced intensity HLA- haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases [ J ]. Bone Marrow Transplant, 2008,42:523 - 527.
8Nishimura J, Smith CA, Phillips KL, et al. Paroxysmal nocturnal hemoglobinuria:molecular pathogenesis and molecular therapeutic approaches[ J]. Hematopathol Mol Hematol, 1998,11 : 119 - 146.
9Rachidi S,Musallam KM,Taher AT. A closer look at paroxysmalnocturnal hemoglobinuria. Eur J Intern Med,2010; 21(4) :260 -267.
10Hill A,Platts PJ,Smith A,et al. The incidence and prevalence ofparoxysmal nocturnal haemoglobinuria ( PNH) and survival ofpatients in Yorkshire. Haematologica,2007 ; 92 (suppl. 2) :25.
